Viewing Study NCT01335620


Ignite Creation Date: 2025-12-25 @ 4:13 AM
Ignite Modification Date: 2025-12-26 @ 3:12 AM
Study NCT ID: NCT01335620
Status: COMPLETED
Last Update Posted: 2019-11-20
First Post: 2011-03-25
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: The Safety, Pharmacokinetic Profile and Efficacy of Raltegravir in HIV-infected Patients at Least 60 Years of Age
Sponsor: Imperial College London
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: RTG_60
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators